These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15526142)

  • 1. Efficacy and tolerability of a botulinum toxin type A free of complexing proteins (NT 201) compared with commercially available botulinum toxin type A (BOTOX) in healthy volunteers.
    Jost WH; Kohl A; Brinkmann S; Comes G
    J Neural Transm (Vienna); 2005 Jul; 112(7):905-13. PubMed ID: 15526142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of a New Botulinum Toxin Type A Free of Complexing Proteins.
    Oh HM; Park JH; Song DH; Chung ME
    Toxins (Basel); 2015 Dec; 8(1):. PubMed ID: 26712786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between botulinum neurotoxin type A2 and type A1 by electrophysiological study in healthy individuals.
    Mukai Y; Shimatani Y; Sako W; Asanuma K; Nodera H; Sakamoto T; Izumi Y; Kohda T; Kozaki S; Kaji R
    Toxicon; 2014 Apr; 81():32-6. PubMed ID: 24495439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of short-term electrical stimulation before and after botulinum toxin injection.
    Santus G; Faletti S; Bordanzi I; Pirali F; De Grandis D
    J Rehabil Med; 2011 Apr; 43(5):420-3. PubMed ID: 21448556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm.
    Roggenkämper P; Jost WH; Bihari K; Comes G; Grafe S;
    J Neural Transm (Vienna); 2006 Mar; 113(3):303-12. PubMed ID: 15959841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin A (Botox) and sweating-dose efficacy and comparison to other BoNT preparations.
    Schlereth T; Mouka I; Eisenbarth G; Winterholler M; Birklein F
    Auton Neurosci; 2005 Feb; 117(2):120-6. PubMed ID: 15664565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological activity of two botulinum toxin type A complexes (Dysport and Botox) in volunteers: a double-blind, randomized, dose-ranging study.
    Wohlfarth K; Schwandt I; Wegner F; Jürgens T; Gelbrich G; Wagner A; Bogdahn U; Schulte-Mattler W
    J Neurol; 2008 Dec; 255(12):1932-9. PubMed ID: 18854916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological study for comparing the effect of biological activity between type A botulinum toxins in rat gastrocnemius muscle.
    Kim CS; Jang WS; Son IP; Nam SH; Kim YI; Park KY; Kim BJ; Kim MN
    Hum Exp Toxicol; 2013 Sep; 32(9):914-20. PubMed ID: 23475433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nerve stimulation boosts botulinum toxin action in spasticity.
    Frasson E; Priori A; Ruzzante B; Didonè G; Bertolasi L
    Mov Disord; 2005 May; 20(5):624-9. PubMed ID: 15726575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Effect of Botulinum Toxin A Injections into the Extensor Digitorum Brevis Muscle after Local Mechanical Leg Vibration: A Case Report.
    Hefter H; Beek J; Rosenthal D; Samadzadeh S
    Toxins (Basel); 2021 Jun; 13(6):. PubMed ID: 34203875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does vitamin B alter the efficacy of botulinum toxin?
    Tatlidede S; Baslo MB; Özkaya Ö; Soydan T; Orhan EK; Yeşilada AK
    Aesthetic Plast Surg; 2012 Jun; 36(3):692-7. PubMed ID: 22395300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurophysiological double-blind trial of a botulinum neurotoxin type a free of complexing proteins.
    Wohlfarth K; Müller C; Sassin I; Comes G; Grafe S
    Clin Neuropharmacol; 2007; 30(2):86-94. PubMed ID: 17414940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute neurophysiologic effects of botulinum toxin type A intramuscular injection on extensor digitorum brevis muscle in healthy adults.
    Boulias C; Ismail F; Phadke CP
    Toxicon; 2022 May; 211():6-10. PubMed ID: 35283163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of biological activity of four botulinum toxin type A preparations in mice.
    Chung ME; Song DH; Park JH
    Dermatol Surg; 2013 Jan; 39(1 Pt 2):155-64. PubMed ID: 23301819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of reconstituted and stored botulinum toxin type A: an electrophysiologic and visual study in the auricular muscle of the rabbit.
    Jabor MA; Kaushik R; Shayani P; Ruiz-Razura A; Smith BK; Morimoto KW; Cohen BE
    Plast Reconstr Surg; 2003 Jun; 111(7):2419-26; discussion 2427-31. PubMed ID: 12794491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of botulinum-A toxin to cremaster muscle: an experimental study.
    Cakmak M; Cağlayan F; Erdemoğlu AK; Ulusoy S
    Urol Res; 2003 Oct; 31(5):352-4. PubMed ID: 14574542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstituted botulinum toxin type A does not lose potency in humans if it is refrozen or refrigerated for 2 weeks before use.
    Sloop RR; Cole BA; Escutin RO
    Neurology; 1997 Jan; 48(1):249-53. PubMed ID: 9008526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin treatment of extraocular muscles in rabbits results in increased myofiber remodeling.
    Ugalde I; Christiansen SP; McLoon LK
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4114-20. PubMed ID: 16249488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Questioning the need to use Botox within 4 hours of reconstitution: a study of fresh vs 2-week-old Botox.
    Yang GC; Chiu RJ; Gillman GS
    Arch Facial Plast Surg; 2008; 10(4):273-9. PubMed ID: 18645097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of Clostridium botulinum toxin type A injections on motor unit activity of the deep digital flexor muscle in healthy sound Royal Dutch sport horses.
    Wijnberg ID; Hardeman LC; van der Meij BR; Veraa S; Back W; van der Kolk JH
    Vet J; 2013 Dec; 198 Suppl 1():e147-51. PubMed ID: 24360760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.